Mesirow Financial Investment Management Inc. Has $325,000 Position in iShares Biotechnology ETF $IBB

Mesirow Financial Investment Management Inc. lessened its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 57.9% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 2,571 shares of the financial services provider’s stock after selling 3,531 shares during the period. Mesirow Financial Investment Management Inc.’s holdings in iShares Biotechnology ETF were worth $325,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Ramirez Asset Management Inc. acquired a new position in shares of iShares Biotechnology ETF during the 1st quarter valued at $26,000. Berkshire Money Management Inc. acquired a new position in shares of iShares Biotechnology ETF during the 2nd quarter valued at $28,000. Financial Gravity Asset Management Inc. acquired a new position in shares of iShares Biotechnology ETF during the 1st quarter valued at $30,000. Woodside Wealth Management LLC acquired a new position in shares of iShares Biotechnology ETF during the 1st quarter valued at $31,000. Finally, Harbor Asset Planning Inc. acquired a new position in shares of iShares Biotechnology ETF during the 2nd quarter valued at $31,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 1.3%

iShares Biotechnology ETF stock opened at $159.38 on Friday. iShares Biotechnology ETF has a 12-month low of $107.43 and a 12-month high of $159.79. The firm’s fifty day moving average is $146.78 and its 200 day moving average is $134.29.

iShares Biotechnology ETF Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 19th. Shareholders of record on Tuesday, September 16th were issued a dividend of $0.0828 per share. The ex-dividend date was Tuesday, September 16th. This represents a $0.33 annualized dividend and a yield of 0.2%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.